A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
- PMID: 30117265
- PMCID: PMC6209538
- DOI: 10.1002/ajmg.c.31637
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
Abstract
Tuberous sclerosis complex (TSC) is associated with a wide range of behavioral, psychiatric, intellectual, academic, neuropsychological, and psychosocial difficulties, which are often underdiagnosed and undertreated. Here, we present a clinical update on TSC-associated neuropsychiatric disorders, abbreviated as "TAND," to guide screening, diagnosis, and treatment in practice. The review is aimed at clinical geneticists, genetic counselors, pediatricians, and all generalists involved in the assessment and treatment of children, adolescents and adults with TSC, and related disorders. The review starts with a summary of the construct and levels of TAND, before presenting up-to-date information about each level of investigation. The review concludes with a synopsis of current and future TAND research.
Keywords: ADHD; TANDTSC; anxiety; autism spectrum disorder; behavior; depression; mental health; neuropsychological deficits; scholastic difficulties.
© 2018 The Authors. American Journal of Medical Genetics Part C: Seminars in Medical Genetics published by Wiley Periodicals, Inc.
Similar articles
-
TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.Orphanet J Rare Dis. 2018 Sep 10;13(1):157. doi: 10.1186/s13023-018-0901-8. Orphanet J Rare Dis. 2018. PMID: 30201051 Free PMC article.
-
The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.Orphanet J Rare Dis. 2020 Sep 7;15(1):237. doi: 10.1186/s13023-020-01488-4. Orphanet J Rare Dis. 2020. PMID: 32894194 Free PMC article.
-
Is It Feasible to Identify Natural Clusters of TSC-Associated Neuropsychiatric Disorders (TAND)?Pediatr Neurol. 2018 Apr;81:38-44. doi: 10.1016/j.pediatrneurol.2017.12.006. Epub 2018 Jan 31. Pediatr Neurol. 2018. PMID: 29530301
-
[Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].Z Kinder Jugendpsychiatr Psychother. 2019 Mar;47(2):139-153. doi: 10.1024/1422-4917/a000604. Epub 2018 Aug 6. Z Kinder Jugendpsychiatr Psychother. 2019. PMID: 30080117 Review. German.
-
The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.J Neurodev Disord. 2022 Feb 13;14(1):13. doi: 10.1186/s11689-022-09423-3. J Neurodev Disord. 2022. PMID: 35151277 Free PMC article.
Cited by
-
Behavioral Symptoms May Correlate With the Load and Spatial Location of Tubers and With Radial Migration Lines in Tuberous Sclerosis Complex.Front Neurol. 2021 Oct 22;12:673583. doi: 10.3389/fneur.2021.673583. eCollection 2021. Front Neurol. 2021. PMID: 34744957 Free PMC article.
-
Abnormal activation of Yap/Taz contributes to the pathogenesis of tuberous sclerosis complex.Hum Mol Genet. 2022 Jun 22;31(12):1979-1996. doi: 10.1093/hmg/ddab374. Hum Mol Genet. 2022. PMID: 34999833 Free PMC article.
-
Quality of life in children with tuberous sclerosis complex: A pediatric cohort study.CNS Neurosci Ther. 2021 Mar;27(3):280-288. doi: 10.1111/cns.13473. Epub 2020 Nov 23. CNS Neurosci Ther. 2021. PMID: 33225634 Free PMC article.
-
Validation of the self-report quantified Tuberous Sclerosis Complex-Associated Neuropsyciatric Disorders Checklist (TAND-SQ).Orphanet J Rare Dis. 2025 Jun 13;20(1):304. doi: 10.1186/s13023-025-03642-2. Orphanet J Rare Dis. 2025. PMID: 40514711 Free PMC article.
-
Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex.Nat Commun. 2022 Aug 9;13(1):4665. doi: 10.1038/s41467-022-31961-6. Nat Commun. 2022. PMID: 35945201 Free PMC article.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Psychiatric Disorders. 5. Arlington, VA: American Psychiatric Publishing; 2013.
-
- Asato MR, Hardan AY. Neuropsychiatric problems in tuberous sclerosis complex. Journal of Child Neurology. 2004;19(4):241–249. - PubMed
-
- Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, … Budde K. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. 2013;381(9869):817–824. doi: 10.1016/S0140-6736(12)61767-X. - DOI - PubMed
-
- Bolton PF, Park RJ, Higgins JNP, Griffiths PD, Pickles A. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain. 2002;125(6):1247–1255. - PubMed
Publication types
MeSH terms
Grants and funding
- Novartis/International
- Curemark, LLC/International
- Texas Higher Education Coordinating Board (THECB)/International
- Cerebra Centre for Neurodevelopmental Disorders/International
- National Research Foundation/International
- Health Resources and Service Administration (HRSA)/International
- T73MC22236/Leadership Education in Neurodevelopmental and Related Disorders (LEND)/International
- 602391/EPISTOP/International
- U01 NS092595/NS/NINDS NIH HHS/United States
- U54 NS092090/NS/NINDS NIH HHS/United States
- NS082320/NH/NIH HHS/United States
- U01 NS082320/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical